Marlow et al. [144] conducted a pilot study using C-reactive protein (CRP) [145] and a micronucleus assay [146] as inflammation biomarkers and gut microbiota transcriptomics to test the ability of the MD to reduce inflammation in Crohn’s disease. Here, CRP is linked to Crohn disease.